Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC ATCC PDM-166 (HCM-BROD-0019-C25) Patient-Derived Pancreatic Adenocarcinoma Organoid Model
Supplier: ATCC HCMBROD0019C25
ATCC PDM-166 (HCM-BROD-0019-C25) is a patient-derived organoid model isolated from a primary pancreatic adenocarcinoma. This BSL 1 organoid is intended for basic cancer research and pharmacological screening, providing a biologically relevant in vitro model of pancreatic tumor tissue.
- Derived from primary pancreatic adenocarcinoma tissue.
- Organoid cell model suitable for in vitro cancer research.
- Biosafety level 1; follow institutional biosafety procedures.
- Applicable to pharmacological screening and tumor biology studies.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?